These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 18790198)
1. Alemtuzumab induction with tacrolimus monotherapy in de novo renal transplantation. Villanueva ME; Muñoz AS; Casasola CC; Africa JB; Danguilan RA; Ona ET Transplant Proc; 2008 Sep; 40(7):2222-5. PubMed ID: 18790198 [TBL] [Abstract][Full Text] [Related]
2. Experience with Alemtuzumab (Campath-1H) as induction agent in renal transplantation followed by steroid-free immunosuppression. Baez Y; Giron F; Niño-Murcia A; Rodríguez J; Salcedo S Transplant Proc; 2008 Apr; 40(3):697-9. PubMed ID: 18454990 [TBL] [Abstract][Full Text] [Related]
3. Preliminary experience with alemtuzumab induction therapy combined with maintenance low-dose tacrolimus monotherapy in small-bowel transplantation in China. Yuan-Xin L; Ning L; You-Sheng L; Xiao-Dong N; Ming L; Jian W; Jie-Shou L Transplant Proc; 2010; 42(1):29-34. PubMed ID: 20172275 [TBL] [Abstract][Full Text] [Related]
4. Alemtuzumab induction therapy in highly sensitized kidney transplant recipients. Lü TM; Yang SL; Wu WZ; Tan JM Chin Med J (Engl); 2011 Mar; 124(5):664-8. PubMed ID: 21518554 [TBL] [Abstract][Full Text] [Related]
5. Pediatric living donor kidney transplantation under alemtuzumab pretreatment and tacrolimus monotherapy: 4-year experience. Tan HP; Donaldson J; Ellis D; Moritz ML; Basu A; Morgan C; Vats AN; Erkan E; Shapiro R Transplantation; 2008 Dec; 86(12):1725-31. PubMed ID: 19104412 [TBL] [Abstract][Full Text] [Related]
6. Campath-1H (alemtuzumab) as an induction agent for the prevention of graft rejection and preservation of renal function in kidney transplant patients: Philippine 3-year follow-up. Muñoz AS; Cabanayan-Casasola CB; Danguilan RA; Padua FB; Ona ET Transplant Proc; 2008 Sep; 40(7):2230-3. PubMed ID: 18790200 [TBL] [Abstract][Full Text] [Related]
7. Pilot study of rapid steroid elimination with alemtuzumab induction therapy in kidney and pancreas transplantation. Sundberg AK; Roskopf JA; Hartmann EL; Farney AC; Rohr MS; Stratta RJ Transplant Proc; 2005 Mar; 37(2):1294-6. PubMed ID: 15848701 [TBL] [Abstract][Full Text] [Related]
8. Alemtuzumab versus interleukin-2 receptor antibodies induction in living donor kidney transplantation. Sampaio MS; Kadiyala A; Gill J; Bunnapradist S Transplantation; 2009 Oct; 88(7):904-10. PubMed ID: 19935462 [TBL] [Abstract][Full Text] [Related]
9. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation. Farney AC; Doares W; Rogers J; Singh R; Hartmann E; Hart L; Ashcraft E; Reeves-Daniels A; Gautreaux M; Iskandar SS; Moore P; Adams PL; Stratta RJ Transplantation; 2009 Sep; 88(6):810-9. PubMed ID: 19920781 [TBL] [Abstract][Full Text] [Related]